Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?

Disease Markers

Volumn 29, Issue 5, 2010, Pages 265-273

  Verschuren, J J W ^a   Sampietro, M L ^a,g   Pons, D ^a,g   Trompet, S ^a   Ewing, M M ^a   Quax, P H A ^a   De Knijff, P ^a   Zwinderman, A H ^b   De Winter, R J ^b,g   Tio, R A ^c,g   De Maat, M P ^d   Doevendans, P A F M ^e,g   Jukema, J W ^a,f,g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f Durrer Center for Cardiogenetic Research   (Netherlands)

^g ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Matrix metalloproteinases; percutaneous coronary intervention; restenosis; single nucleotide polymorphisms

Indexed keywords

GELATINASE A; STROMELYSIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DATA BASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENDER; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOMICS; HAPLOTYPE MAP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79951518974     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0757     Document Type: Article

References (29)

1. W.R. Agema, P.S. Monraats, A.H. Zwinderman, R.J. de Winter, R.A.Tio, P.A. Doevendans, J. Waltenberger, M.P. de Maat, R.R. Frants, D.E. Atsma, A. van der Laarse, E.E. van der Wall and J.W. Jukema, Current PTCA practice and clinical outcomes in The N (Pubitemid 38834074)
2. J.C. Barrett, B. Fry, J. Maller and M.J. Daly, Haploview: analysis and visualization of LD and haplotype maps, Bioinfor-matics 21 (2005), 263-265. (Pubitemid 40202029)
3. S. Beyzade, S. Zhang, Y.K. Wong, I.N. Day, P. Eriksson and S. Ye, Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction, J Am Coll Cardiol 41 (2003), 2130-2137. (Pubitemid 36724257)
4. K.R. Chiou, S.L. Chung and M.J. Charng, 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting, J Chin Med Assoc 68 (2005), 506-512.
5. M.P. de Maat, J.W. Jukema, S. Ye, A.H. Zwinderman, P.H. Moghaddam, M. Beekman, J.J. Kastelein, A.J. van Boven, A.V. Bruschke, S.E. Humphries, C. Kluft and A.M. Henney, Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis, Am J Cardiol 83 (1999), 852-856. (Pubitemid 29143120)
6. M. Fatar, M. Stroick, M. Steffens, E. Senn, B. Reuter, S. Bukow, M. Griebe, A. Alonso, P. Lichtner, P. Bugert, T. Meitinger, T.F. Wienker and M.G. Hennerici, Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes, Cerebrovasc Dis 26 (2008), 113-119.
7. J. Ge, C. Shen, C. Liang, L. Chen, J. Qian and H. Chen, Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis, International Journal of Cardiology 112 (2006), 85-90. (Pubitemid 44247183)
8. M.A. Hlatky, E. Ashley, T. Quertermous, D.B. Boothroyd, P. Ridker, A. Southwick, R.M. Myers, C. Iribarren, S.P. Fort-mann and A.S. Go, Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute my-ocardial infarction among patients with coronary artery disease, Am Heart J 154 (2007), 1043-1051. (Pubitemid 350116029)
9. Y. Hojo, U. Ikeda, T. Katsuki, O. Mizuno, H. Fujikawa and K. Shimada, Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty, Atherosclerosis 161 (2002), 185-192. (Pubitemid 34214835)
10. P. Hoppmann, W. Koch, A. Schomig and A. Kastrati, The 5A/6A polymorphismofthe stromelysin-1 gene and restenosis after percutaneous coronary interventions, Eur Heart J 25 (2004), 335-341. (Pubitemid 38295443)
11. Y. Hua, L. Song, N. Wu, X. Lu, X. Meng, D. Gu and Y. Yang, Polymorphisms of MMP-2 gene are associated with systolic heart failure risk in Han Chinese, Am J Med Sci 337 (2009), 344-348.
12. S. Humphries, C. Bauters, A. Meirhaeghe, L. Luong, M. Bertrand and P. Amouyel, The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis, Eur Heart J 23 (2002), 721-725. (Pubitemid 35230702)
13. C. Johnson and Z.S. Galis, Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization, Arterioscler Thromb Vasc Bi-ol 24 (2004), 54-60. (Pubitemid 38082411)
14. J.L. Johnson, S.J. George, A.C. Newby and C.L. Jackson, Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries, Proc Natl Acad Sci U S A 102 (2005), 15575-15580. (Pubitemid 41528098)
15. R.C. Kaplan, N.L. Smith, S. Zucker, S.R. Heckbert, K. Rice and B.M. Psaty, Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke, Atherosclerosis 201 (2008), 130-137.
16. K.M. Katsaros, S.P. Kastl, G. Zorn, G. Maurer, J. Wojta, K. Huber, G. Christ and W.S. Speidl, Increased Restenosis Rate After Implantation of Drug-Eluting Stents in Patients With Elevated Serum Activity of Matrix Metalloproteinase-2 and -9, JACC: Cardiovascular Interventions 3 (2010), 90-97.
17. M. Kuzuya, S. Kanda, T. Sasaki, N. Tamaya-Mori, X.W. Cheng, T. Itoh, S. Itohara and A. Iguchi, Deficiency of gelati-nase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia, Circulation 108 (2003), 1375-1381. (Pubitemid 37174417)
18. T.L. Medley, B.A. Kingwell, C.D. Gatzka, P. Pillay and T.J. Cole, Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression, Circ Res 92 (2003), 1254-1261. (Pubitemid 36723654)
19. A.C. Newby, Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates, Cardiovasc Res 69 (2006), 614-624. (Pubitemid 43140745)
20. M.L. Sampietro, D. Pons, K.P. de, P.E. Slagboom, A. Zwin-derman and J.W. Jukema, A genome wide association analysis in the GENDER study, Neth Heart J 17 (2009), 262-264.
21. A. Schwarz, W. Haberbosch, H. Tillmanns and A. Gardemann, The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease, Dis Markers 18 (2002), 121-128. (Pubitemid 35417399)
22. M. Stephens, N.J. Smith and P. Donnelly, A new statistical method for haplotype reconstruction from population data, Am J Hum Genet 68 (2001), 978-989. (Pubitemid 32289743)
23. M. Stephens and P. Donnelly, A comparison of bayesian methods for haplotype reconstruction from population genotype data, Am J Hum Genet 73 (2003), 1162-1169. (Pubitemid 37414228)
24. M. Stephens and P. Scheet, Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation, Am J Hum Genet 76 (2005), 449-462. (Pubitemid 40250525)
25. A. Vasku, M. Goldbergova, L.I. Holla, L. Spinarova, J. Spinar, J. Vitovec, and J. Vacha, Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure, Clin Chem Lab Med 41 (2003), 1299-1303. (Pubitemid 37266117)
26. A. Vasku, M. Goldbergova, H.L. Izakovicova, L. Siskova, L. Groch, M. Beranek, S. Tschoplova, V. Znojil and J. Vacha, A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease, Matrix Biol 22 (2004), 585-591. (Pubitemid 38283782)
27. S. Wallenstein, S.E. Hodge and A. Weston, Logistic regression model for analyzing extended haplotype data, Genet Epidemiol 15 (1998), 173-181. (Pubitemid 28166541)
28. S. Ye, P. Eriksson, A. Hamsten, M. Kurkinen, S.E. Humphries and A.M. Henney, Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression, J Biol Chem 271 (1996), 13055-13060. (Pubitemid 26175880)
29. S. Ye, Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome, Cardiovasc Res 69 (2006), 636-645. (Pubitemid 43139726)